Vous avez cherché: µ (Grec - Anglais)

-,, µ?
- 0 .3

-- 5 µ .
ecb staff will then make the photocopies .

5.2 µ
pharmacokinetic properties

� π � � � � � � µ � � � � �
a private secured d ata ro m w here your help grow m y busi n es ?

��� ��� �π������ µ � � � � � � � � �
d g enterp rise - in o v ation / s m es p rogram e

������������ �� �π������� ������� ��� ������������ �π������µ������ �������
gate2growth.comisthehomeforseveral investors and s e r together a com unity of entrepreneurs,

e velosulin µ
to inject velosulin on its own

4.8 a 0 µ
undesirable effects

5.1 µ µ
pharmacodynamic properties

Λατε τ µ%νυµα;
get the message?

µ νοτσιχάλυοτ 32 g
emulsion for injection

ησόδ αίΜ υοίλοβµε µ:
qualitative and quantitative composition

2006 1,7 µ . δ .
2006 1.7 n.a. 1.7 n.a. 1.9

ηνϊετωρποκυλγ Ε µ νοτσιχάλυοτ
use

0,5 ml (10 µ/ml)
0.5 ml (10 µ/ml)

(eß d? µ? d e?)
ut n=number of subjects at baseline, week 12, week 24, week 36, week 48, week 60, week 72,

������ ����µ���� �π������� ����µπ�������µ����
es, w e are s incubator p ro com it ed to your c es, in d u s t r in venture cap ital p or d e rs t and fer ings.

µ (# 181;) σύμβολο Μικρό -
µ (#181;) micro sign

a oµ velosulin µ µ o o
to mix velosulin with long acting insulin

5.3 n o µ (f)o
preclinical safety data